VOTING AGREEMENT among: MADRIGAL PHARMACEUTICALS, INC., a Delaware corporation; SYNTA PHARMACEUTICALS CORP., a Delaware corporation; and the undersigned StockholderVoting Agreement • April 14th, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
Contract Type
FiledApril 14th, 2016
Company
Industry
Jurisdiction
THIS VOTING AGREEMENT (“Agreement”), dated as of April [·], 2016, is made by and among Synta Pharmaceuticals Corp., a Delaware corporation (“Synta”), Madrigal Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
AMENDED AND RESTATED VOTING AGREEMENT among: CATALYST BIOSCIENCES, INC., a Delaware corporation; TARGACEPT, INC., a Delaware corporation; and the undersigned Stockholder Dated as of May 13, 2015Voting Agreement • May 14th, 2015 • Targacept Inc • Pharmaceutical preparations • Delaware
Contract Type
FiledMay 14th, 2015
Company
Industry
Jurisdiction
THIS AMENDED AND RESTATED VOTING AGREEMENT (“Agreement”), dated as of May 13, 2015, is made by and among Targacept, Inc., a Delaware corporation (“Targacept”), Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
VOTING AGREEMENT among: CATALYST BIOSCIENCES, INC., a Delaware corporation; TARGACEPT, INC., a Delaware corporation; and the undersigned Stockholder Dated as of March 5, 2015Voting Agreement • March 6th, 2015 • Targacept Inc • Pharmaceutical preparations • Delaware
Contract Type
FiledMarch 6th, 2015
Company
Industry
Jurisdiction
THIS VOTING AGREEMENT (“Agreement”), dated as of March 5, 2015, is made by and among Targacept, Inc., a Delaware corporation (“Targacept”), Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.
VOTING AGREEMENTVoting Agreement • March 6th, 2015 • Targacept Inc • Pharmaceutical preparations • Delaware
Contract Type
FiledMarch 6th, 2015
Company
Industry
Jurisdiction
THIS VOTING AGREEMENT (“Agreement”), dated as of March 5, 2015, is made by and among Targacept, Inc., a Delaware corporation (“Targacept”), Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of Targacept.
VOTING AGREEMENTVoting Agreement • April 16th, 2014 • Zalicus Inc. • Pharmaceutical preparations • Delaware
Contract Type
FiledApril 16th, 2014
Company
Industry
Jurisdiction
THIS VOTING AGREEMENT (“Agreement”), dated as of April 15, 2014, is made by and among Zalicus Inc., a Delaware corporation (“Phoenix”), Epirus Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of the Company.